Abingdon Health PLC Directorate Change (4411Q)
18 October 2023 - 5:00PM
UK Regulatory
TIDMABDX
RNS Number : 4411Q
Abingdon Health PLC
18 October 2023
Abingdon Health plc
("Abingdon Health" or "the Company")
Directorate Change
York, U.K. 18 October 2023: Abingdon Health plc (AIM: ABDX), a
leading international lateral flow contract research (CRO) and
contract development and manufacturing organisation (CDMO),
announces that Mrs Melanie Ross, CFO, will resign as a Director of
the Company with immediate effect and will leave Abingdon Health on
30 November 2023. Abingdon Health expects to appoint an interim
Finance Director shortly who will therefore benefit from a handover
period.
Dr Chris Hand, Non-Executive Chairman said: "On behalf of the
Board of Directors of Abingdon Health plc, I would like to thank
Melanie Ross for her contribution to the Company and wish her well
for the future."
Enquiries
Abingdon Health plc www.abingdonhealth.com/investors/
Chris Yates, Chief Executive Officer Via Walbrook PR
Chris Hand, Non-Executive Chairman
Singer Capital Markets (Sole Broker and
Nominated Adviser)
Peter Steel, Alex Bond (Corporate Finance) Tel: +44 (0)20 7496 3000
Tom Salvesen (Corporate Broking)
Walbrook PR Limited
Paul McManus / Phillip Marriage
Alice Woodings Tel: +44 (0)20 7933 8780 or abingdon@walbrookpr.com
About Abingdon Health plc
Abingdon Health is a leading lateral flow contract research
(CRO) and contract development and manufacturing organisation
("CDMO") offering its services to an international customer base
across industry sectors that include clinical, animal health, plant
health, and environmental testing. Abingdon Health has the internal
capabilities to take projects from initial concept through to
routine and large-scale manufacturing; from "idea to commercial
success."
The Company's CDMO division offers product development,
regulatory support, technology transfer and manufacturing services
for customers looking to develop new assays or transfer existing
laboratory-based assays to a lateral flow format. Abingdon Health
aims to support the increase in need for rapid results across many
industries and locations and produces lateral flow tests in areas
such as infectious disease, clinical testing including companion
diagnostics, animal health and environmental testing. Faster access
to results allows for rapid decision making, targeted intervention
and can support better outcomes.
Abingdon Health's Abingdon Simply Test (TM) range of self-tests
is an ecommerce platform that offers a range of self-tests to
empowers consumers to manage their own health and wellbeing. The
Abingdon Simply Test (TM) ecommerce site offers consumers a range
of information to support them in making informed decisions on the
tests available. In addition, the site provides Abingdon's contract
services customers with a potential route to market for self-tests.
The Abingdon Simply Test range is also sold through international
distributors and through other channels in the UK and Ireland such
as pharmacy chains.
Founded in 2008, Abingdon Health is headquartered in York,
England.
For more information visit: www.abingdonhealth.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOAZZMMGNNFGFZM
(END) Dow Jones Newswires
October 18, 2023 02:00 ET (06:00 GMT)
Abingdon Health (LSE:ABDX)
Historical Stock Chart
From Apr 2024 to May 2024
Abingdon Health (LSE:ABDX)
Historical Stock Chart
From May 2023 to May 2024